Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Vojtech Petr

TitlePost-Doctoral Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Petr V, Thurman JM. The role of complement in kidney disease. Nat Rev Nephrol. 2023 Dec; 19(12):771-787. PMID: 37735215.
      View in: PubMed
    2. Zahradka I, Petr V, Jakubov K, Modos I, Hruby F, Viklicky O. Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine. Front Med (Lausanne). 2023; 10:1252822. PMID: 37795416.
      View in: PubMed
    3. Eskandari SK, Gaya da Costa M, Faria B, Petr V, Azzi JR, Berger SP, Seelen MAJ, Damman J, Poppelaars F. An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes. Am J Transplant. 2022 12; 22 Suppl 4:45-57. PMID: 36453708.
      View in: PubMed
    4. Petr V, Zahradka I, Modos I, Roder M, Prewett A, Fialova M, Machkova J, Hruba P, Magicova M, Slavcev A, Striz I, Viklicky O. First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft. Transplantation. 2023 02 01; 107(2):e62-e64. PMID: 36314999.
      View in: PubMed
    5. Zahradka I, Petr V, Modos I, Kabrtova K, Slavcev A, Viklicky O. SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation. Transplantation. 2022 12 01; 106(12):e522-e524. PMID: 36245078.
      View in: PubMed
    6. Petr V, Csuka D, Hruba P, Szil?gyi ?, Kollar M, Slavcev A, Proh?szka Z, Viklicky O. MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy. Front Immunol. 2022; 13:985766. PMID: 36189289.
      View in: PubMed
    7. Zahradka I, Petr V, Modos I, Magicova M, Dusek L, Viklicky O. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report. Ann Intern Med. 2022 07; 175(7):961-968. PMID: 35500256.
      View in: PubMed
    8. Zahradka I, Petr V, Magicova M, Viklicky O. Background risk should be taken into account when reporting vaccine effectiveness. Am J Transplant. 2022 07; 22(7):1927-1928. PMID: 35043536.
      View in: PubMed
    9. Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O, Abramowicz D, Naik M, Mayer G, Oberbauer R. Waiting Time for Second Kidney Transplantation and Mortality. Clin J Am Soc Nephrol. 2022 01; 17(1):90-97. PMID: 34965955.
      View in: PubMed
    10. Petr V, Hruba P, Kollar M, Krejci K, Safranek R, Stepankova S, Dedochova J, Machova J, Zieg J, Slatinska J, Pokorna E, Viklicky O. Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss. Transplant Direct. 2021 Nov; 7(11):e779. PMID: 34712779.
      View in: PubMed
    11. Cahova M, Kveton M, Petr V, Funda D, Dankova H, Viklicky O, Hruba P. Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney Blood Press Res. 2021; 46(2):245-249. PMID: 33756485.
      View in: PubMed
    Petr's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)